Ali Sabbagh • UCSF Profiles

Ali Sabbagh, MD

Title(s)	Postdoctoral Scholar, Radiation Oncology
School	School of Medicine
Address	1600 Divisadero, #001 San Francisco CA 94115
Phone	415-476-9065
vCard	Download vCard

Bibliographic

Publications

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.

Altmetrics Details

PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.

Machine learning and explainable artificial intelligence to predict pathologic stage in men with localized prostate cancer. Prostate. 2025 Jan; 85(1):3-12. Semwal H, Ladbury C, Sabbagh A, Mohamad O, Tilki D, Amini A, Wong J, Li YR, Glaser S, Yuh B, Dandapani S. PMID: 39400372.

View in: PubMed Mentions: 1 Fields:
Uro Urology
Translation:Humans
Quantification of the environmental impact of radiotherapy and associated secondary human health effects: a multi-institutional retrospective analysis and simulation. Lancet Oncol. 2024 Jun; 25(6):790-801. Lichter KE, Charbonneau K, Lewy JR, Bloom JR, Shenker R, Sabbagh A, Chino J, Rodrigues A, Hearn J, Grover S, Sheu RD, Witztum A, Qureshi MM, Yom SS, Anand C, Thiel CL, Mohamad O. PMID: 38821084.

View in: PubMed Mentions: 2 Fields:
Neo Neoplasms
Translation:Humans
Safety of high-dose-rate brachytherapy in patients with prostate cancer and inflammatory bowel disease: A case series. J Contemp Brachytherapy. 2024 Feb; 16(1):1-5. Thomas H, Chen JJ, Shaheen H, Sabbagh A, Abdul-Baki H, Chau OW, Malik N, Ayoub A, Hassanzadeh C, Hsu IC, Mohamad O. PMID: 38584887; PMCID: PMC10993899.

View in: PubMed Mentions:
Reducing the Environmental Impact of Health Care Conferences: A Study of Emissions and Practical Solutions. JCO Glob Oncol. 2024 Feb; 10:e2300209. Lichter KE, Sabbagh A, Demeulenaere S, Drew T, Conway A, Nogueira L, Suneja G, Kirkwood K, Hampshire K, Gundling K, Teherani A, Thottathil SE, Mohamad O. PMID: 38359373; PMCID: PMC10881111.

View in: PubMed Mentions: Fields:
Neo Neoplasms
Translation:Humans
Safety of high-dose rate (HDR) brachytherapy for patients with prostate cancer and history of prior chemoradiation for rectal cancer: A case series. Brachytherapy. 2024 Mar-Apr; 23(2):173-178. Thomas H, Chen JJ, Abdul-Baki H, Sabbagh A, Shaheen H, Chau OW, Malik N, Ayoub A, Hassanzadeh C, Hsu IC, Mohamad O. PMID: 38160102.

View in: PubMed Mentions: Fields:
Rad Radiotherapy
Translation:Humans
A case of cetuximab-induced radiation recall skin dermatitis and review of the literature. Radiat Oncol J. 2023 Dec; 41(4):292-296. Sabol RA, Patel AM, Sabbagh A, Wilson C, Yuen F, Lindenfeld P, Aggarwal R, Breyer B, Mohamad O. PMID: 38185934; PMCID: PMC10772596.

View in: PubMed Mentions:
Multi-institutional Development and External Validation of a Machine Learning Model for the Prediction of Distant Metastasis in Patients Treated by Salvage Radiotherapy for Biochemical Failure After Radical Prostatectomy. Eur Urol Focus. 2024 Jan; 10(1):66-74. Sabbagh A, Tilki D, Feng J, Huland H, Graefen M, Wiegel T, Böhmer D, Hong JC, Valdes G, Cowan JE, Cooperberg M, Feng FY, Mohammad T, Shelan M, D'Amico AV, Carroll PR, Mohamad O. PMID: 37507248.

View in: PubMed Mentions: Fields:
Uro Urology
Translation:Humans
Hypofractionation Adoption in Prostate Cancer Radiotherapy: Results of an International Survey. JCO Glob Oncol. 2023 Jun; 9:e2300046. Sabbagh A, Weiss J, Tawk B, Mohammed MA, Abdulbaki H, Moraes FY, Grover S, Yap ML, Zubizarreta E, Lievens Y, Rodin D, Mohamad O. PMID: 37319396; PMCID: PMC10497301.

View in: PubMed Mentions: Fields:
Neo Neoplasms
Translation:Humans
Evaluating the Environmental Impact of Radiation Therapy Using Life Cycle Assessments: A Critical Review. Int J Radiat Oncol Biol Phys. 2023 11 01; 117(3):554-567. Lichter KE, Charbonneau K, Sabbagh A, Witztum A, Chuter R, Anand C, Thiel CL, Mohamad O. PMID: 37172916.

View in: PubMed Mentions: 1 Fields:
Neo Neoplasms Rad Radiology Rad Radiotherapy
Translation:Humans Animals
Development and External Validation of a Machine Learning Model for Prediction of Lymph Node Metastasis in Patients with Prostate Cancer. Eur Urol Oncol. 2023 Oct; 6(5):501-507. Sabbagh A, Washington SL, Tilki D, Hong JC, Feng J, Valdes G, Chen MH, Wu J, Huland H, Graefen M, Wiegel T, Böhmer D, Cowan JE, Cooperberg M, Feng FY, Roach M, Trock BJ, Partin AW, D'Amico AV, Carroll PR, Mohamad O. PMID: 36868922.

View in: PubMed Mentions: 6 Fields:
Neo Neoplasms Uro Urology
Translation:Humans
Outcomes of salvage high dose-rate brachytherapy with or without pelvic external beam radiotherapy in patients with palpable local recurrence of prostate cancer after radical prostatectomy. Brachytherapy. 2023 May-Jun; 22(3):304-309. Ni L, Chen K, Phuong C, Sabbagh AR, Wong AC, Mohamad O, Hsu IC. PMID: 36623988.

View in: PubMed Mentions: Fields:
Rad Radiotherapy
Translation:Humans
Management of Patients with Recurrent and Metachronous Oligometastatic Prostate Cancer in the Era of PSMA PET. Cancers (Basel). 2022 Dec 15; 14(24). Sabbagh A, Mohamad O, Lichter KE, Hope TA. PMID: 36551678; PMCID: PMC9777467.

View in: PubMed Mentions: 6